The QualityStocks Daily Tuesday, September 17th, 2024

Today's Top 3 Investment Newsletters

MarketClub Analysis(GLMD) $15.1000 +290.18%

Premium Stock Alerts(SMSI) $1.1400 +117.97%

Schaeffer's(PLCE) $17.4000 +42.51%

The QualityStocks Daily Stock List

Neonode (NEON)

Wall Street Resources, StreetInsider, QualityStocks, TradersPro, Jason Bond, Money Morning, BUYINS.NET, TraderPower, MarketBeat, OTCPicks, WealthMakers, Greenbackers, INO.com Market Report, Real Pennies, StreetAuthority Daily, The Street, MicrocapAlliance, FeedBlitz, TopStockAnalysts, Top Gun, Investing Futures, InvestorPlace, Investors Alley, The Stock Psycho, Red Chip, MarketClub Analysis, Smartmoneytrading, MicrocapVoice, The Online Investor, The Momentum Traders Network, Penny Detectives, StockMarketWatch, Stock Guru, RedChip and Marketbeat.com reported earlier on Neonode (NEON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Neonode Inc. (NASDAQ: NEON) (FRA: SB6P) is focused on the development of optical sensing solutions for in-cabin monitoring, gesture sensing, touch and contactless touch.

The firm has its headquarters in Stockholm, Sweden and was incorporated in 1997, on September 4th by Thomas Eriksson Bjorn. It serves consumers in China, South Korea, Japan and the United States, as well as internationally.

The company licenses its technology to Tier 1 suppliers and original equipment manufacturers. It also offers embedded sensors to Tier 1 suppliers, original design manufacturers and original equipment manufacturers. The company serves the automotive, avionics, medical, office equipment and consumer electronics industries worldwide. It derives the majority of its revenue from the United States. It is also organized in four wholly owned subsidiaries, which are located in Taiwan, Korea, Japan and Sweden.

The enterprise develops gesture and optical touch solutions for human interaction with devices. Its patented optical interactive sensing technology has been developed for devices like e-readers, tablets, mobile phones, monitors, PC devices, printers and automotive systems. In addition to this, the enterprise is involved in the sale of Neonode branded sensor products like AirBar products, via its distributors. Its other trademarks include MultiSensing and zForce. The enterprise also provides cost-effective driver and cabin monitoring solutions for vehicles, based on its software platform. Furthermore, it is engaged in the provision of engineering consulting services.

The firm is focused on strengthening its team in order to capitalize on the growing market opportunities, which will not only bring in more investors into the firm and also boost the firm’s growth significantly.

Neonode (NEON), closed Tuesday's trading session at $11.92, up 35.1474%, on 2,338,572 volume. The average volume for the last 3 months is 949,003 and the stock's 52-week low/high is $1.02/$11.94.

Datasea Inc. (DTSS)

QualityStocks, StockMarketWatch, MarketClub Analysis, TradersPro, StockEarnings, TopPennyStockMovers, Profitable Trader Authority, Buzz Stocks, ChineseWire, Early Bird, InsiderTrades, OTCtipReporter, Penny Pick Finders, 360 Wall Street, PennyStockScholar, StockOnion, StocksEarning, The Online Investor, Tim Bohen and PennyStockProphet reported earlier on Datasea Inc. (DTSS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Datasea Inc. (NASDAQ: DTSS) is an early-stage firm that is focused on the provision of security and software solutions.

The firm has its headquarters in Beijing, the People’s Republic of China and was incorporated in 2014, on September 26th by Xing Zhong Sun, Fu Liu and Zhi Xin Liu. Prior to its name change in October 2015, the firm was known as Rose Rock Inc. It operates as part of the technology sector, under the software and tech services industry and serves consumers across the globe.

The company offers elevator risk warning solutions, network security audit, smart linkage precaution systems and smart security solutions mainly to newly founded operating entities, partner agents, scenic or tourist attractions, schools and public communities via its own sales teams.

The enterprise develops a trio of smart security products, including the public community security system, the scenic area security system and the safe campus security system. It also develops smart 3D security and big data security platforms, as well as an epidemic system and provides data integration, data analysis and media advertising services. This is in addition to offering and developing education-related technologies to build science education platforms, education cloud platforms, education management systems and campus networks, as well as other education systems utilized in learning institutions.

The company’s wholly-owned subsidiary recently entered into 6 purchase and distribution agreements to provide 5G MMCP to companies located in different parts of China. The move will facilitate the expansion of its distribution network, which will not only have a positive effect on the company’s revenue and growth but also on investments into the firm.

Datasea Inc. (DTSS), closed Tuesday's trading session at $2.94, up 29.8013%, on 40,521,994 volume. The average volume for the last 3 months is 174,902 and the stock's 52-week low/high is $1.42/$20.29.

Sonoma Pharmaceuticals (SNOA)

QualityStocks, StockMarketWatch, MarketClub Analysis, TradersPro, MarketBeat, The Stock Dork, StockEarnings, InvestorPlace, BUYINS.NET, AwesomeStocks, The Online Investor and StreetInsider reported earlier on Sonoma Pharmaceuticals (SNOA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) (FRA: O8Z3) is a specialty pharmaceutical firm that is focused on the development and production of stabilized hypochlorous acid products for different applications, including oral care, eye care, animal health care, wound care and dermatological conditions.

The firm has its headquarters in Woodstock, Georgia and was incorporated in April 1999 by Linda Alimi and Hojabr Alimi. Prior to its name change in December 2016, the firm was known as Oculus Innovative Sciences Inc. The firm serves consumers around the globe.

The enterprise’s product portfolio is made up of a HOCl-based product dubbed Acuicyn, to help relieve inflammation and itching around the eye; SebuDerm, for relief and management of itching, pain and burning associated with seborrheic dermatitis and seborrhea; Celacyn gel, which has been developed to promote healing through the management of old and new scars; a HOCl-based prescription product dubbed Levicyn, which has been developed to manage pain, itching and burning; and an antimicrobial facial cleanser dubbed Epicyn. It also develops Lasercyn gel to manage skin irritations; an atopic dermatitis hydrogel dubbed Pediacyn; a treatment of topical mild to moderate acne dubbed Gramaderm; a HOCl-based solution known as MicrocynAH, for relief of scratches, hot spots and irritated skin in animals. In addition to this, the enterprise develops Sinudox for nasal irrigation and a surface disinfectant known as Microsafe. It generates revenue from product sales around the globe.

Sonoma Pharmaceuticals (SNOA), closed Tuesday's trading session at $5.2, up 23.5154%, on 2,391,627 volume. The average volume for the last 3 months is 961,264 and the stock's 52-week low/high is $2.318/$18.96.

Portage Biotech (PRTG)

QualityStocks, MarketBeat, Zacks, The Online Investor, Premium Stock Alerts and FreeRealTime reported earlier on Portage Biotech (PRTG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Portage Biotech, Inc. (NASDAQ: PRTG) is focused on conducting research on and developing biotechnology and pharmaceutical products.

The firm has its headquarters in Tortola, the British Virgin Islands and was incorporated in 1973 by Gregory H. Bailey. It operates as part of the biotechnology industry under the healthcare sector. The firm serves consumers around the globe.

The company identifies and develops first-in-class and best-in-class products and clinical programs which will maximize its potential returns. Its portfolio is made up of subsidiary firms whose technologies and products have established scientific rationales, including virus-like particles, intratumorals, cell penetrating peptides and liposomes.

The enterprise’s product pipeline comprises of a blood-conditioning technology dubbed SBI-101, which restores balance to the immune system after an individual experiences acute injuries to their vital organs; a cell permeable peptide platform known as CellPorter, which is based on human proteins; and an ophthalmic solution dubbed PPL-003. It also develops a formulation dubbed INT230-6, which is undergoing phase II trials looking into its effectiveness in treating solid tumors; a PLGA-nanoparticle combined with an NY-ESO-1 peptide vaccine dubbed IMM65; and an iNKT cell activator known as IMM60. The enterprise also develops a small molecule known as Sting, which has been designed to bind to the interferon gene stimulator in cancer.

The firm, which recently released its latest financial results, remains focused on accelerating its lead clinical programs in an effort to execute its unique drug development strategy. This will bring in more growth opportunities into the firm and positively influence investments as well.

Portage Biotech (PRTG), closed Tuesday's trading session at $4.53, up 15.5612%, on 101,886 volume. The average volume for the last 3 months is 1.764M and the stock's 52-week low/high is $2.098/$59.13.

Talkspace Inc. (TALK)

Global Alert, QualityStocks, MarketBeat, InvestorPlace, TradersPro, Global Equity Alert, Greenbackers, Marketbeat.com, PennyStockLaboratory, Top Stock Tips, PennyStockInformer, Zacks, BestDamnPennyStocks, Lions of Wall Street, PHUB News, Real Pennies, TheNextBigTrade, FeedBlitz, DSR News and MarketClub Analysis reported earlier on Talkspace Inc. (TALK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Talkspace Inc. (NASDAQ:TALK) is a virtual behavioral healthcare firm that is focused on delivering healthcare through encrypted mobile and web platforms, consistent with HIPAA and other state regulatory requirements.

The firm has its headquarters in New York and was incorporated in 2012 by Frank Oren and Frank Roni. Prior to its name change, the firm was known as Hudson Executive Investment Corp. It serves consumers in the United States.

The company is committed to making mental health care more convenient, accessible and effective. Its mission is to make individuals around the globe happy with its unlimited messaging therapy, which affords consumers access to licensed, professional therapists without having to book appointments.

The enterprise addresses the challenges of conventional mental healthcare by combining technology with effective clinical solutions. It operates a platform which provides confidential therapy with a network of licensed therapists.The platform was designed with the intention of providing quality therapy services that help guide patients on what they can do to improve their mental state and lead a better life. It is powered by a team of certified mental health specialists in various states who offer psychiatric treatment and therapy for adolescents, couples and individuals. The therapists on this platform meet clients on their schedules, wherever they are, on any device, via video, voice and chat.

Talkspace Inc. (TALK), closed Tuesday's trading session at $2.17, up 13.6126%, on 21,732,079 volume. The average volume for the last 3 months is 2.562M and the stock's 52-week low/high is $1.41/$3.92.

Senseonics Holdings (SENS)

MarketClub Analysis, Schaeffer's, InvestorPlace, TradersPro, MarketBeat, TraderPower, StreetInsider, StockMarketWatch, BUYINS.NET, The Street, SmallCap Network, QualityStocks, Trades Of The Day, Penny Stock 101, StockRockandRoll, InsiderTrades, Equities.com, Daily Trade Alert and PennyStockLocks reported earlier on Senseonics Holdings (SENS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Senseonics Holdings Inc. (NYSE American: SENS) (FRA: 6L6) is a medical technology firm that is engaged in developing and commercializing CGM systems for individuals with diabetes.

The firm has its headquarters in Germantown, Maryland and was incorporated in 2014, on June 26th. It operates as part of the professional and commercial equipment and supplies merchant wholesalers’ industry. The firm has two companies in its corporate family and serves consumers in the United States, as well as in Africa, the Middle East and Europe.

The company’s goal is to help people with diabetes not only manage the disease but also allow them to live their lives with ease. It uses its fluorescence sensing technology to design its continuous glucose monitoring system, which is the pioneer fully implantable system that is both highly stable and accurate, throughout its sensor life. The company serves patients and healthcare provides via strategic fulfillment partners and a network of distributors.

The enterprise’s products include implantable CGM (continuous glucose monitoring) systems dubbed the Eversense XL and Eversense, which can measure the levels of glucose in individuals with diabetes via an under the skin sensor. The systems also have an application that monitors diabetes in real-time and manages it for a period between 90-180 days as well as a rechargeable and removable smart transmitter.

Senseonics Holdings (SENS), closed Tuesday's trading session at $0.4354, up 10.3396%, on 44,295,870 volume. The average volume for the last 3 months is 2.792M and the stock's 52-week low/high is $0.32/$0.75.

iLearningEngines (AILE)

MarketBeat and QualityStocks reported earlier on iLearningEngines (AILE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

iLearningEngines Holdings Inc. (NASDAQ: AILE) (NASDAQ: AILEW) is an artificial intelligence platform for learning automation.

The firm has its headquarters in Bethesda, Maryland and was incorporated in 2010. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers around the world.

iLearningEngines’ goal is to create the preeminent AI ecosystem that empowers companies to make themselves better at what they do. It combines its offerings with vertically focused capabilities and data models to operationalize AI and automation to address critical challenges facing its customers effectively and efficiently. It empowers its customers to productize their institutional knowledge by transforming it into actionable intellectual property that enhances outcomes for employees, customers and other stakeholders.

The enterprise's AI learning and engagement platform provides a cloud-based, mobile, offline, and multimedia capabilities that is used to deliver personalized learning and engagement modules. Its platform includes the Learning Experience Platform, that addresses the corporate learning market; and Information Intelligence Platform which addresses the information management, analytics, and automation markets. In addition, the enterprise develops an in-process learning platform that enables organizations to deliver learning in the flow of day-to-day activities.

The firm recently entered a strategic partnership with Exult Global, entailing the implementation of its innovative AI platform on Microsoft Fabric and Azure. This strategic move strengthens iLearningEngines’ customer offering and better positions it for sustained growth in the rapidly evolving AI markets. This may, in turn, encourage more investors into the firm and generate additional value for its shareholders.

iLearningEngines (AILE), closed Tuesday's trading session at $1.38, up 13.1148%, on 6,993,620 volume. The average volume for the last 3 months is 25.455M and the stock's 52-week low/high is $0.7083/$20.00.

Alphabet (GOOGL)

The Street, InvestorPlace, Kiplinger Today, Zacks, The Online Investor, Schaeffer's, Daily Trade Alert, Investopedia, Trades Of The Day, Market Intelligence Center Alert, Money Morning, Early Bird, MarketBeat, MarketClub Analysis, StreetInsider, Uncommon Wisdom, StreetAuthority Daily, Top Pros' Top Picks, Wealth Insider Alert, Daily Profit, StrategicTechInvestor, Wyatt Investment Research, The Street Report, Wall Street Daily, The Wealth Report, TopStockAnalysts, Money and Markets, CustomerService, Louis Navellier, AllPennyStocks, MarketWatch, StocksEarning, All about trends, Investing Daily, Daily Wealth, TipRanks, ProfitableTrading, Stansberry Research, CNBC Breaking News, INO.com Market Report, Marketbeat.com, Investors Alley, INO Market Report, MarketTamer, MarketArmor.com, QualityStocks, Market Intelligence Center, Darwin Investing Network, Trading Tips, Power Profit Trades, InvestorGuide, Stock Up Featured, InsiderTrades, Options Elite, Barchart, InvestorIntel, DividendStocks, Money Wealth Matters, Cabot Wealth, Total Wealth, The Night Owl, StockEarnings, SmallCapNetwork, Daily Dividends, GorillaTrades, TheOptionSpecialist, WStreet Market Commentary, FreeRealTime, The Daily Market Alert, Insider Wealth Alert, Jon Markman’s Pivotal Point, Dynamic Wealth Report, Investiv, Investing Futures, Trader Prep, The Weekly Options Trader, Investing Signal, Investor Guide, InvestorsObserver Team, Eagle Financial Publications, SmallCap Network, Short Term Wealth, Smartmoneytrading, StockMarketWatch, The Motley Fool, Trading Concepts, Chaikin PowerFeed, Average Joe Options, Market Authority, Trade of the Week, 24/7 Trader, Investing Lab, Jim Cramer, Wealth Daily, TradingPub, Equities.com, The Wall Street Transcript, Investment House, Shah's Insights & Indictments, Financials Trends, Inside Investing Daily, Investing Breakout, Investment U, Earnings360 Newsletter, Stock Barometer, TrendAdvisor, Tradespoon, TradeSmith Daily, Traders For Cash Flow, Top Pros Top Picks, The Trading Report, The Stock Dork, RedChip, BUYINS.NET, ChartAdvisor, Profit Confidential, Lance Ippolito, Mind Over Markets, StockReport, Pennystockmania, CNBC, Contrarian Outlook, Schaeffer’s, bullseyeoptiontrading, BillionDollarClub, Beat The Street, empirefinancialresearch, Earnings360, 360 Wall Street, Day Trade Alert, Candle Stick Forum, Energy and Capital, Economic News Room, Dividend Opportunities, Energy & Resources Digest, StreetAuthority Financial, Rockwell Trading, Roundtable Roundup, SECFilings.com News, SmallCapVoice, Smart Investing Today, Smart Money Press, SmartTrading, Microcapmillionaires, Street Insider, PoliticsAndMyPortfolio.com, Summa Money, SwingTradeOnline, SystemTrading, Technology Profits Daily, Tim Bohen, Tim Sykes, wyatt research newsletter, Stock Gumshoe, Liberty Through Wealth, Greenbackers, HotStockProfits and iDigital Market reported earlier on Alphabet (GOOGL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alphabet (NASDAQ: GOOGL, GOOG), a tech giant known, through Google, for its search engine and a plethora of digital services, is currently under the microscope for its acquisition strategies, particularly the purchase of AdMeld in 2011. This move, as reported by TechXplore on Sept. 17, 2024, is being scrutinized in an antitrust trial led by the Justice Department. The trial accuses Google of buying up emerging competitors, such as DoubleClick in 2008 and Invite Media, to cement its dominance in the online advertising market. This strategy is seen as an attempt to eliminate competition and control a larger share of the online ad tools sector.

The government’s case against Google points out that after acquiring DoubleClick, Google saw yield management tools, which are crucial for websites to set ad prices, as a potential threat to its ad exchange platform. Despite initially underestimating the technology, Google recognized the rising influence of companies like AdMeld. This led to the acquisition of AdMeld for over $400 million, a figure well above its estimated value, and its subsequent integration into Google’s advertising exchange, effectively shutting down the product. This move is portrayed as a deliberate effort to stifle competition and maintain Google’s leading position in the ad market.

Neal Mohan, then a prominent figure in Google’s display advertising division and now YouTube CEO, was instrumental in the acquisition of AdMeld. His actions and communications during the process indicate that Google was not merely filling a gap in its portfolio but was actively working to eliminate a competitor. Mohan’s comparison of Google’s AdX to streaming video, while dismissing AdMeld and similar technologies as outdated, underscores the strategic importance of the acquisition in keeping Google competitive against rivals like Yahoo Inc. and Microsoft Corp.

This antitrust trial against Google highlights the company’s aggressive tactics to dominate the online advertising sector. It raises critical questions about the fine line between business expansion and the maintenance of fair competition. The outcome of this case could significantly impact Google’s future strategies and the broader tech industry’s approach to mergers and acquisitions.

Alphabet continues to perform robustly in the stock market. With a stock price of $158.92, marking a slight increase, and a market capitalization of about $1.96 trillion, Alphabet remains a formidable player in the tech industry. The fluctuation in its stock price, ranging from a low of $120.21 to a high of $191.75 over the past year, reflects the dynamic nature of the market and investor sentiment towards the company amidst ongoing legal challenges.

To view the company’s latest earnings release, visit https//ibn.fm/1vFFk

About Alphabet Inc.

Alphabet is a collection of companies, the largest of which is Google. Larry Page and Sergey Brin founded Google in September 1998 and the company is headquartered in Mountain View, California. Billions of people use its wide range of popular products and platforms each day, like Search, Ads, Chrome, Cloud, YouTube and Android. For more information, visit the company’s website at www.ABC.xyz.

Alphabet (GOOGL), closed Tuesday's trading session at $159.32, up 0.7971656%, on 20,715,612 volume. The average volume for the last 3 months is 1.278M and the stock's 52-week low/high is $120.2057/$191.75.

Viper Energy (VNOM)

MarketBeat, Stansberry Research, InvestorPlace, Investing Daily, DividendStocks, Daily Trade Alert, StreetInsider, MarketClub Analysis, The Online Investor, Trades Of The Day, Investors Alley, The Street Report, InvestmentHouse, Schaeffer's, Marketbeat.com, TradersPro, FreeRealTime, Market Intelligence Center Alert, Top Pros' Top Picks, Zeke Truligio, StockMarketWatch, StreetAuthority Daily, The Street, Trading Concepts, InsiderTrades, The Best Newsletters, Zacks and Market FN reported earlier on Viper Energy (VNOM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Viper Energy (NASDAQ: VNOM), a company that owns and acquires mineral and royalty interests in oil and natural gas properties, has released the pricing of an underwritten public offering. The offering is comprised of 10,000,000 shares of its class A common stock, offered at $42.50 per share. According to the announcement, the offering, which closed on Sept. 13, 2024, represents a 1,500,000 share upsize to the originally proposed 8,500,000 share offering.

In addition, Viper granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of class A common stock; that option was exercised. Total gross proceeds from the offering reached an estimated 488.8 million, with net proceeds for the company totaling approximately $475.9 million. Viper anticipates using the funds from the offering for its pending acquisition of certain mineral and royalty-interest owning subsidiaries of Tumbleweed Royalty IV LLC (the “Pending Acquisition”). Roth Capital Partners acted as comanager for the offering.

To view the full press release, visit https://ibn.fm/wVYol

About Viper Energy Inc.

Viper Energy is a publicly traded Delaware corporation that owns and acquires mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin. For more information about the company, please visit www.ViperEnergy.com.

Viper Energy (VNOM), closed Tuesday's trading session at $44.84, up 3.5088%, on 1,762,485 volume. The average volume for the last 3 months is 439,719 and the stock's 52-week low/high is $26.7269/$49.3699.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, PsychedelicNewsWire, Daily Trade Alert, Top Pros' Top Picks, StreetInsider, Schaeffer's, Prism MarketView, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Last week, representatives of various federal agencies met to discuss new treatments for post-traumatic stress disorder (PTSD), including psychedelics. Speakers at the event included representatives from the Veterans Affairs department, Substance Abuse and Mental Health Services Administration, the U.S. Food and Drug Administration (FDA), the U.S. Department of Health and Human Services and the U.S. Department of Defense.

The event was hosted by the Reagan-Udall Foundation for the FDA. While it didn’t center on psychedelic-assisted treatments only, many exchanged views on the topic.

During the discussion, those attending acknowledged the potential of psychedelics in treating post-traumatic stress disorder and highlighted the need for further studies to ensure patient safety and drug effectiveness.

For example, Betty Aldworth, MAPS director of communications and post-prohibition strategy, stated that the meeting demonstrated the increasing public interest in psychedelic-assisted treatments. In a statement after the event, Aldworth revealed that the U.S. Veterans Affairs Administration, some members of Congress, patient advocates, trauma experts and some stakeholders all gave testimonies agreeing that the evidence base for psychedelic-assisted treatments warranted even more support.

She added that the time had come to close the gap on new pharmacotherapies for treating post-traumatic stress disorder by bringing psychedelic-assisted treatments into the healthcare system.

Aldworth’s statement comes only weeks after the FDA rejected an application that would have approved the use of MDMA in treating post-traumatic stress disorder. In its decision, the FDA directed that another phase 3 trial be conducted to investigate the effectiveness of MDMA in treating the disorder.

A separate study, whose findings were reported in the “Journal of Psychedelic Studies,” determined that despite encouraging results from clinical trials, more research was needed before MDMA-assisted therapy was adopted as a treatment.

Meanwhile, the VA recently started accepting requests for funding to conduct research on psilocybin and MDMA-assisted treatments for a range of mental-health conditions. The acting director of the Clinical Science, Research and Development Service, Miriam J. Smyth, revealed that opportunities for veterans to volunteer would be announced once the studies began.

In other news, bipartisan legislators held an event at the U.S. Capitol asking that the FDA approve the use of MDMA. The legislators also launched an art installation that memorialized military veterans who have died by suicide.

Meanwhile, amendments to a spending legislation that would permit doctors under Veterans Affairs to issue medical cannabis recommendations to military veterans were recently approved by the U.S. House of Representatives. The amendments also encouraged the department to support research into psychedelic benefits in the treatment of medical conditions that affected military veterans.

As more federal agencies recognize the therapeutic potential of psychedelics in treating a variety of health conditions, more attention is likely to be paid to the work that various entities, such as Compass Pathways PLC (NASDAQ: CMPS), are doing to advance the field of psychedelic medicine.

Compass Pathways PLC (CMPS), closed Tuesday's trading session at $7.22, up 0.2777778%, on 248,233 volume. The average volume for the last 3 months is 1.38M and the stock's 52-week low/high is $5.01/$12.75.

Momo Inc. (MOMO)

QualityStocks, StocksEarning, MarketClub Analysis, StockEarnings, InvestorPlace, Schaeffer's, Marketbeat, Market Intelligence Center Alert, Zacks, The Street, Trades Of The Day, Kiplinger Today, Daily Trade Alert, StreetInsider, The Street Report, Marketbeat.com, FreeRealTime, BUYINS.NET, The Online Investor, INO.com Market Report, ChineseWire, TipRanks, Louis Navellier, TradersPro, Trading Concepts, Wealth Insider Alert, StreetAuthority Daily, TopStockAnalysts, Investopedia, Money Morning, DividendStocks, Daily Wealth, PennyDoctor, Greenbackers, StockMarketWatch, StocksImpossible, Street Insider, OTCBB Journal, Early Bird, First Penny Picks, ChartAdvisor, Barchart, CrashTrade, Investing Signal, InvestmentHouse, Jason Bond, AskSlapper, Orbit Stocks, Profit Confidential, Promotion Stock Secrets, Short Term Wealth, Terry's Tips, The Best Newsletters, The Stock Dork and One Hot Stock reported earlier on Momo Inc. (MOMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Dating applications have become increasingly inundated with fake profiles run by scammers looking to take advantage of unsuspecting users. While the majority of dating app scams seek to defraud, some scams involve crimes as serious as trafficking and are incredibly damaging to both users and the dating platforms themselves.

Recently published research revealed that three in five users suspect the profiles they interact with to be fake. This has become such a significant issue in the virtual dating space that a growing number of users are now swearing off online dating apps such as Tinder and Bumble in favor of in-person dating.

So how can the tens of millions of people who still use dating platforms remain safe from phony profiles?

Watch out for users who ask to move the conversation to different platforms quickly. Scammers tend to use this tactic because it grants them access to addresses and phone numbers. Additionally, be wary of profiles that look too good to be true. Some scammers will design their profiles and conversations to make them seem more appealing and attract potential matches.

Take everything that users say with a pinch of salt, especially if they seem overly protective, caring or considerate from the beginning. You should also be wary of users who aren’t willing to meet in person after an appropriate amount of time. While it is natural that you would want to know your matches better before meeting in person, a user who continually postpones such meetings could be avoiding in-person interactions to mask dishonorable intentions.

Similarly, scam profiles will regularly make plans to meet in person but then cancel them. If you notice that one of your matches is consistently canceling meet-up plans, you may be interacting with a scammer behind a fake profile. Another major red flag in online dating is requests for financial aid. A scammer’s ultimate intention is to quickly build a relationship with unsuspecting users and solicit financial support.

You should also be suspicious of matches that ask personal questions early into the conversation. This includes asking about information such as your phone number, home address, and driver’s license or passport numbers. With this in mind, you will want to make sure you keep all your personal information to yourself, especially if you are still in the early talking stages.

Finally, make sure you approach online dating with a healthy dose of suspicion. Watch out for profiles that seem suspicious in any way, avoid sharing your personal information, use verification methods such as video calls to confirm a matches’ identity and make sure to report profiles that seem suspicious.

The increasing cases of scams on dating apps are creating the urgent need for entities such as Momo Inc. (NASDAQ: MOMO) to weed out scammers so that genuine users of those platforms can have their needs met.

Momo Inc. (MOMO), closed Tuesday's trading session at $6.32, up 0.3174603%, on 609,859 volume. The average volume for the last 3 months is 500,887 and the stock's 52-week low/high is $4.79/$7.745.

Cresco Labs Inc. (CRLBF)

QualityStocks, InvestorPlace, Kiplinger Today, Daily Trade Alert, MarketBeat, Cabot Wealth, CannabisNewsWire, Top Pros' Top Picks, The Street, The Wealth Report, Wealth Insider Alert, Trading For Keeps, Trades Of The Day, The Online Investor, Early Bird, Prism MarketView, StreetInsider, wyatt research newsletter, TradersPro and StocksEarning reported earlier on Cresco Labs Inc. (CRLBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Back in 2018 when Congress passed the current farm bill that legalized hemp, Congress seemed to have been under the belief that hemp was for making rope rather than intoxicating products. However, the current debate around hemp is almost solely rotating around intoxicants.

It has become abundantly clear that the law passed in 2018, in a way, spawned the current proliferation of derivatives, including THC products. There is a heated debate, with people on either side making arguments in support of their positions. For example, the hemp industry wants the current law to remain as it is, leaving makers of hemp-derived THC intoxicants to operate in the current legal gray area. They claim that the phrasing “all derivatives” opened the gate to THC products from hemp and the status quo should remain.

Opponents argue that THC products from hemp aren’t under the purview of any regulatory framework and that is untenable, since any product intended for the market should be regulated in one way or the other.

One factor has become clear as efforts are made to close the so-called “hemp loophole”: the congressional committees that are responsible for formulating hemp policy aren’t the right entities to make laws giving the U.S. Food and Drug Administration (FDA) power over any product. The committees simply oversee agriculture. This explains why, up until now, no regulations have been passed guiding the FDA on how CBD should make its way onto the market or into different consumable products.

Even if the upcoming farm bill was used to provide guidance on THC derived from hemp, it creates more challenges than it solves. For example, would states that have permitted hemp intoxicants renew their laws at least once every five years? Secondly, the Drug Enforcement Administration specifically categorizes synthetic THC as a schedule 1 substance, and not even the reclassification of marijuana would change this classification.

It is becoming increasingly clear that whether THC is derived from marijuana or hemp, it needs to be regulated by a single legal regime. This could mean that manufacturers of hemp-sourced THC products have to adhere to new or existing laws on product testing, advertising, marketing and more. Insisting that the product continue to exist within a “loophole” is counterproductive for the industry in more ways than one. For example, institutional investors are likely to be unwilling to fund such ventures since the segment is open to all manner of legal challenge.

Now may be the time to establish the right regulatory framework for hemp, so that the growth of the industry isn’t left to chance because this risks not only public health but also the very economic interests of those currently engaged in hemp derivative manufacturing.

Regulatory clarity on all forms of THC would help the hemp and cannabis industry, including companies such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF), to be more certain about the conditions under which they should expect to operate and make their future plans.

Cresco Labs Inc. (CRLBF), closed Tuesday's trading session at $1.67, off by 1.7647%, on 299,226 volume. The average volume for the last 3 months is 32,603 and the stock's 52-week low/high is $1.0552/$2.65.

The QualityStocks Company Corner

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlightFathom Nutriband Inc. (NASDAQ: NTRB) .

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, has authorized a share repurchase program to buy back up to $1 million of its common stock. According to the announcement, as of Sept. 16, 2024, the company had 11,106,185 shares of common stock outstanding. The company also reported that it is continuing to make progress on the development of AVERSA Fentanyl, with a target date of submitting a New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") in the first half of 2025.

To view the full press release, visit https://ibn.fm/HhBZ9

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico and Australia.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Nutriband Inc. (NASDAQ: NTRB), closed Tuesday's trading session at $5.62, up 24.3363%, on 90,079 volume. The average volume for the last 3 months is 3.834M and the stock's 52-week low/high is $1.53/$9.595.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software and services, announced that it is holding the first-ever Qubits UAE 2024 quantum computing event in Dubai. D-Wave is hosting the event with Staque, a leading consulting and development practice in AI, blockchain and quantum computing, with the support of Staque's regional partner SquareOne. Scheduled for September 20, 2024, Qubits UAE will showcase "success powered by quantum today" through real-world business optimization use cases, progress in quantum-driven AI technology, and demonstrations of annealing quantum computing performance over traditional computing.

"We're witnessing a remarkable moment in computing, as annealing quantum technology transitions from exploration to enterprise use, capable of driving measurable impact for customers today," commented Dr. Alan Baratz, CEO of D-Wave. "We're honored to host Qubits UAE 2024 with Staque and SquareOne to show UAE-based organizations the transformative potential annealing quantum computing can have on both commercial and research endeavors in the country."

To view the full press release, visit https://ibn.fm/sEhgN

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Tuesday's trading session at $0.9979, up 1.4745%, on 1,245,669 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $9.595/$.

Recent News

Torr Metals Inc. (TSX.V: TMET)

The QualityStocks Daily Newsletter would like to spotlightFathom Torr Metals Inc. (TSX.V: TMET) .

Torr Metals (TSX.V: TMET), a Vancouver-based mineral exploration company, today announced that it has opened a non-brokered private placement. As part of the private placement, the company will issue up to 2,142,857 flow-through ("FT") shares at $0.14 per share and up to 3,000,000 non-flow-through ("NFT") units of the company at $0.10 per unit. Each FT share will consist of one common share of the company, while each NFT unit will consist of one NFT common share of the company and one-half of one warrant. Torr Metals expects to raise up to $600,000 in aggregate gross proceeds.

To view the full press release, visit https://ibn.fm/DEYUt

Torr Metals Inc. (TSX.V: TMET) operates as a mineral exploration company focusing on the identification, acquisition, and advancement of mineral properties. With full 100% ownership of over 1,000 square kilometers of gold and copper projects strategically positioned in premier low-cost mining jurisdictions, Torr is poised for substantial returns across various promising regions.

The company’s extensive portfolio encompasses multiple district-scale projects, including the Filion Gold Project in northern Ontario, the Kolos Copper-Gold Project in south-central British Columbia, and the Latham Copper-Gold Project in northern British Columbia. These projects are all located in prolific mining regions with paved highway access, robust support infrastructure, and favorable geological conditions offering significant potential for new discoveries.

Headquartered in Vancouver, British Columbia, Torr Metals is ideally situated to leverage its expertise and resources for continued exploration and growth.

Projects

Kolos Copper-Gold Project

Situated within British Columbia’s prime copper-producing belt, the 140-square-kilometer Kolos Copper-Gold Project exhibits Nicola Belt geology similar to notable porphyry mines, including Copper Mountain and Highland Valley, respectively situated 106 kilometers to the south and 30 kilometers to the northwest.

With field operations based in the nearby city of Merritt and year-round access provided via Highway 5, the Kolos Project showcases substantial discovery upside potential with five defined large-scale copper-gold-molybdenum anomalies untested by drilling.

Torr Metals’ primary focus lies in unlocking the potential for major new discoveries at the Kolos Copper-Gold Project, with recent surface geochemical results marking a significant milestone positioning the company as a new key player in the region.

Filion Gold Project

The 261-square-kilometer Filion Project is situated within a largely unexplored greenstone belt where gold was initially discovered in the 1930s. With a comparable geological setting to regional orogenic gold deposits and multiple newly identified and undrilled gold trends in surficial geochemistry, the Filion Project holds significant district-scale exploration promise.

The Filion Project benefits from unparalleled infrastructure access, with direct drive-on access from the Trans-Canada Highway, as well as a regional railway and power grid four kilometers to the south. Additionally, the nearby town of Kapuskasing, with a population of 8,300, provides essential support services.

This strategic positioning ensures the Filion Project’s viability for cost-effective, year-round operations in an area poised for untapped discovery potential.

Latham Copper-Gold Project

Situated in British Columbia’s renowned Golden Triangle, the Latham Project spans a vast 689-square-kilometer district, offering immense potential for multiple major discoveries. Accessible year-round via Highway 37, just 20 kilometers south of the town of Dease Lake, the site is strategically located amidst established mining infrastructure, including the active Red Chris mine to the southeast and upcoming major porphyry projects at Schaft Creek and Galore Creek along-trend to the southwest.

Highlighted by the Gnat Pass copper-gold porphyry deposit dating back to the 1960s, the Latham Project presents a compelling opportunity for significant expansion and potential discovery. A non-compliant indicated resource at the Gnat Pass deposit includes 33 million tonnes at 0.39% copper, open beyond 200 meters vertical depth, alongside six drill-ready kilometer-scale copper-gold exploration targets.

Moreover, the Latham Project’s appeal corresponds to the region being an attractive destination for major asset acquisitions and takeovers. Recent transactions within a 40-kilometer radius include Newmont’s 2021 acquisition of the Saddle North copper-gold porphyry deposit for $311 million and Newcrest’s investment in the Red Chris copper-gold porphyry deposit in 2019 for $804 million, underscoring industry acknowledgment of the region’s potential.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 that the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

Likewise, a report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Malcolm Dorsey, P.Geo., is President, CEO and Director of Torr Metals. He brings over a decade of expertise as a seasoned exploration geologist and project developer, having been pivotal in driving the success of numerous diverse projects across North, Central, and South America. His comprehensive background spans early-stage exploration through to resource development and project acquisitions. His academic credentials include an M.Sc. in Geology and Geophysics from the University of Calgary, where his research characterized the district-scale structural influences affecting copper and gold mineralizing events in western British Columbia. Prior to his current role, he served as Senior Geologist for Benchmark Metals, where his contributions were instrumental in advancing the company’s gold equivalent resource from approximately 80,000 ounces to a maiden resource estimate of 2.92 million ounces.

John Williamson, P. Geol., is Chairman and Director of Torr Metals. He is a mining executive and investor with more than 30 years of experience as a founder, promoter and leader in the formation, financing and operation of private and public companies with exploration and mining interests worldwide. On more than one occasion his team’s efforts have been recognized for excellence by being named to the TSX Venture 50. He holds a B.Sc. in Geology and is a registered Professional Geologist (P.Geol.) with the Association of Professional Engineers and Geoscientists (APEGA) and the Geological Association of Canada.

Torr Metals Inc. (TSX.V: TMET), closed Tuesday's trading session at $28.47, off by 0.2802102%, on 4 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $24.01/$31.90.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Last week, health regulators in the state of Missouri visited Prime Fuel gas station in Sedalia, looking to see if the store had any intoxicating THC edibles in stock. In their report, the regulators revealed that the store had taken the products off the shelves, noting that they called the owner, who agreed to destroy the products voluntarily. Craig Katz, Missouri Hemp Trade Association's spokesman, claims this isn't how the owner described the incident. However, leaders in the hemp industry claimed that the order also affected products that had undergone laboratory testing, weren't attractive to minors and were sold only to consumers aged 21 years of age and older. The evolving regulatory landscape for various hemp derivatives is likely to impact how various entities, such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), pivot to different product lines in the foreseeable future.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Tuesday's trading session at $0.012, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

For those feeling uncertain about the future of cryptocurrencies, here is some good news. A fresh Consensys report has revealed that Web3 professionals are seriously optimistic about what's coming next. Despite the regulatory uncertainties looming — especially with the 2024 U.S. presidential election on the horizon — 86% of professionals are confident about cryptocurrencies' future. So why are they feeling so positive? The Consensys survey shows that even with the regulatory concerns that worried many, the confidence of Web3 professionals is rock solid. According to Sarah Howe, Consensys' executive director of talent acquisition, Web3 enthusiasts are driven by blockchain's core value. Things such as transparency, decentralization and freedom motivate people to stay committed. The report indicates that 75% of those surveyed believe that the technology's promise of making a positive difference in the world is too compelling to ignore. Overall, while regulatory uncertainty is currently a hot topic, Web3 professionals are keeping a positive attitude and are excited about the future of crypto. With evolving payment preferences, plenty of flexibility and a wide range of job opportunities, it looks like the Web3 community is ready for whatever comes next. This optimism is bound to grow given that many companies, such as Horizon Fintex, are increasing warming up to Web3 solutions tailored to their lines of business.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an electric vehicle ("EV") manufacturer, is adding to its EV dealership network. According to the company, premier full-service dealer Papé Kenworth has become Mullen's seventh franchise dealer partner. Based in Eugene, Oregon, Papé Kenworth, which is part of the Papé Group, has more than 30 locations and is the West's premiere, full-service Kenworth truck dealer. The dealership is partnering with Mullen to provides zero-emissions trucks for a wide range of applications as it supports customers that are adapting to comply with evolving regulations.

"Papé Kenworth is a hallmark dealer and distributor with unmatched and deep experience in supporting the nation's fleet to meet its equipment and logistics needs," said Mullen Automotive CEO and chair David Michery in the press release. "Their extensive reach and expertise in the commercial vehicle industry will play a crucial role in introducing Mullen's commercial EVs to a broader market."

To view the full press release, visit https://ibn.fm/qVUw1

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Tuesday's trading session at $10.45, up 8726.01%, on 1,237,758 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $9.55/$7500.00.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria, a global innovator in drug delivery platforms, is reporting on its eight-week body weight results from its WEIGHT-A24-1 ongoing animal study

The study was made up of three main groups of formulations: DehydraTECH-processed CBD; semaglutide (including "Rybelsus(R)") and liraglutide

The DehydraTECH-CBD and DehydraTECH-liraglutide both outperformed Rybelsus(R), which was a surprise outcome. DehydraTECH-liraglutide posted a weight reduction of 4.74%, the most significant in the study

For Lexaria, this continued outperformance of DehydraTECH-liraglutide is of particular interest, particularly since many third-party studies have shown semaglutide to be more than twice as effective as liraglutide in promoting weight loss

As the study progresses, Lexaria's management is optimistic that it will realize positive and ground-breaking results that will demonstrate the superiority and potential of its technology

Lexaria (NASDAQ: LEXX), a global innovator in drug delivery platforms, is reporting on its eight-week body weight results from its WEIGHT-A24-1 ongoing animal study. This study explores Lexaria's patented technology, DehydraTECH(TM), and its potential in addressing diabetes and weight loss. More importantly, it looks to establish whether DehdyraTECH processing results in higher brain absorption than non-DehydraTECH arms, with a focus on glucagon-like peptide 1 ("GLP-1") drugs, liraglutide and semaglutide (https://cnw.fm/iAhxm).

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Tuesday's trading session at $3.26, off by 3.2641%, on 42,648 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.85/$6.85.

Recent News

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW)

The QualityStocks Daily Newsletter would like to spotlight NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW).

NextPlat (NASDAQ: NXPL), a global e-commerce provider, has released the voting results from its Special Annual Meeting of Stockholders, which was held Sept. 13, 2024. According to the report, shareholder voted on six agenda items, including a proposal to approve and adopt the merger agreement and plan of reorganization making Progressive Care Inc. (OTCQB: RXMD) a wholly owned subsidiary of the company. The proposal was approved, with an anticipated closing date of Oct. 1, 2024. The announcement noted that Progressive Care shareholders also approved the business combination at a special meeting of shareholders held Sept. 13, 2024.

Other items approved by shareholders included a proposal to approve the issuance of more than 20% of the company's issued and outstanding shares of common stock in connection with the business combination, a proposal to elect eight board nominees to the company's board of directors, a proposal to ratify the appointment of RBSM LLP as the company's independent registered public accounting firm for the year, and proposal to approve the compensation of the company's executive officers.

To view the full press release, visit https://ibn.fm/UgApQ

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW), a next generation e-commerce platform, was created with vision and purpose to capitalize on high growth sectors and global markets. The company collaborates with businesses – large and small – to simplify and accelerate online commerce and uniquely enables customers and partners to optimize their e-commerce reach, presence and revenue. NextPlat recently launched a new e-commerce development program to provide American businesses with easy access to the massive Chinese consumer market.

Current Initiatives

NextPlat provides cutting edge technology in an advanced e-commerce ecosystem. The company is actively expanding its global network of online storefronts serving thousands of consumers, enterprises and governments. The company also has developed a next generation platform built for Web3 that enables the creation and sale of digital assets, as well as optimizing e-commerce transactions and business building activities. The company’s current initiatives include:

  • E-Commerce Development Program – In April 2023, NextPlat announced it had entered into a merchant sourcing agreement with Alibaba.com Singapore E-Commerce Private Limited (“Alibaba”) and its Tmall Global e-commerce platform whereby the two companies will collaborate to increase the sale of products produced and sold by American companies to the multi-trillion-dollar Chinese consumer market. Alibaba’s Tmall Global e-commerce platform will provide NextPlat customers a turn-key solution through which products can be sold to the Chinese consumer market. The launch of the Florida E-Commerce Development Program is the first in a series of new NextPlat programs designed to assist U.S. businesses in expanding their online sales capabilities to reach new international customers in the Chinese market. NextPlat intends to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America, as well as Central and South America. The new development program features NextPlat’s turnkey global e-commerce solution for customers and leverages NextPlat’s relationships with key partners, including Tmall Global, China’s largest cross-border B2C online marketplace.
  • Progressive Care Inc. – In August 2022, NextPlat completed a strategic $7 million investment in Progressive Care Inc. (OTCQB: RXMD), a personalized health care services and technology company. In a news release announcing the investment, NextPlat CEO Charles M. Fernandez noted that the company is “committed to harnessing the power of digital technologies to capitalize on the ongoing digital transformation of Progressive Care and the entire health care industry.” NextPlat intends to accelerate Progressive Care’s digital health care transformation with the launch of a new e-commerce platform for health care products later this year.
  • NextPlat NFT Platform – Building on its existing e-commerce initiatives, NextPlat is working to bridge the gap between tangible and digital e-commerce marketplaces by incorporating burgeoning Web3 technologies. The company intends to launch a fully integrated NFT platform in the coming months that will enable brands to create, manage and authenticate digital assets while serving as a new source of revenue for NextPlat. Through this model, the company will receive a portion of the revenue generated from branded NFT drops, as well as subsequent secondary market transactions.
  • Global Telesat Communications and Orbital SatCom Corp. – Targeting both domestic and international markets, NextPlat’s subsidiaries leverage partnerships with major e-commerce platforms such as Amazon, Alibaba, eBay and Walmart to serve a growing base that includes more than 50,000 corporate, governmental and individual customers. In total, the brands market more than 10,000 individual products, with a focus on satellite-based connectivity solutions. In addition to exploring accretive M&A opportunities, NextPlat aims to diversify its range of products and broaden its geographic footprint moving forward in an effort to better capitalize on the tremendous growth potential in the United States, Europe and Asia.

“Our goal for 2023 and beyond is to leverage our improved operational capabilities and enhanced leadership team as we expand our offerings in communications and connectivity into the high-growth health care market where we intend to launch an array of innovative new offerings,” Fernandez said in a March 2023 news release detailing the company’s record top-line performance. “Although there remain supply chain headwinds and the challenge of global inflation, we are confident that we have the right combination of market-tested expertise, technology and partnerships that will enable us to bring the power of e-commerce to more customers, brands and industries in the United States and abroad.”

Market Opportunity

The rapid growth of e-commerce over the last decade is expected to continue for the foreseeable future. According to data published by Forbes, roughly 20.8% of all retail purchases are expected to take place online in 2023, accounting for total sales of $6.31 trillion worldwide. It total, e-commerce sales are expected to grow by 10.4% YoY in 2023, accounting for a whopping 24% of all retail purchases by 2026.

For NextPlat, existing partnerships in the industry could be key to capitalizing on this growth. The Forbes report indicates that Amazon accounts for roughly 38.7% of e-commerce sales, while sites like Walmart, eBay and Alibaba round out the list of most visited e-commerce websites. Alibaba is especially interesting due to NextPlat’s recent strategic merchant sourcing agreement with Tmall Global. The Chinese market is “mammoth,” as a recent Alizila report noted. The country’s annual online retail sales of physical goods have nearly doubled in the last five years, reaching approximately 13.8 trillion yuan in 2022, which is nearly $2 trillion USD.

The health care portion of the e-commerce market is generating particularly bullish forecasts, bolstered by the continued adoption of the 340B Drug Pricing Program in the U.S., which requires most drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices. Industry reports suggest that the global health care e-commerce market will expand at a compound annual growth rate of 16.8% from 2022 to 2030, climbing to a value of more than $1.37 trillion by the end of the forecast period.

Management Team

Charles M. Fernandez, CEO, Executive Chairman and Director of NextPlat, has over three decades of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. Successful across multiple sectors, Fortune Magazine actually labeled Fernandez ‘a restructuring whiz’. As President of Fairholme Capital Management, which he joined in 2008, Mr. Fernandez co-managed all three Fairholme funds and brought in a $2 billion gain for shareholders. Throughout his impressive career, he has participated in more than 100 significant mergers, acquisitions and product development projects across multiple industries. Mr. Fernandez was the founder, Chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK), which was successfully sold to Smartrac, a unit of Avery Dennison Corp. (NYSE: AVY).

Rodney Barreto is Chairman and CEO of the Barreto Group and Director of Nextplat. Mr. Barreto’s business career spans over 35 years, including his role at the Barreto Group and, earlier, as the founding partner of Floridian Partners LLC, a corporate and public affairs consulting firm recognized by policy makers as one of the top in its industry in Florida. He chaired the Super Bowl Host Committee in 2007, 2010 and 2020, helping to raise more than $100 million for the success of Miami Super Bowls. As a philanthropist and conservationist, Mr. Barreto is also a three-time appointee to the Florida Fish and Wildlife Conservation Commission, where he has served for over 10 years including holding the title of Chairman eight times. He has twice chaired the Annual U.S. Conference of Mayors, was Chairman of the 1999 Breeder’s Cup Championship held in South Florida and was the Chairman of the 1999 Sister Cities International Convention in Miami. Currently, Mr. Barreto is the Membership Chairman of the Florida Council of 100, and a member of the Boards of Fairchild Tropical Botanic Garden, the Baptist Health South Florida Giving Society, the Bonefish and Tarpon Trust, the Guy Harvey Ocean Foundation, and a member of Miami Dade County Schools Superintendent Carvalho’s Business Advisory Council. Prior to his career in public affairs and real estate, Mr. Barreto was a City of Miami police officer and is a member of the Florida Highway Patrol Advisory Council.

NextPlat Corp. (NXPL), closed Tuesday's trading session at $1.46, off by 0.6802721%, on 63,327 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.9857/$2.68.

Recent News

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF)

The QualityStocks Daily Newsletter would like to spotlight Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF).

Trillion Energy (CSE: TCF) (OTCQB: TRLEF) (Frankfurt: Z62), a company focused on oil and natural-gas production for Europe and Türkiye, is spotlighted in this week's episode of the MiningNewsWire podcast, which was released by IBN, a multifaceted communications organization. According to the announcement, Trillion Energy CEO and director Dr. Arthur Halleran was the guest on the episode; the Mining NewsWire Podcast features insightful interviews with executives who are shaping the future of the global mining industry.

During the episode, Halleran and podcast host Stuart Smith discussed the company's project portfolio as well as the executive team's background and experience. "When we acquired the company holding these assets in Türkiye, the gas field didn't have any economic gas production or a reserve report," said Trillion Energy CEO and director Dr. Arthur Halleran during the interview. "The facilities were written off. . . .We got a new reserve report and operated the drilling. . . . Leveraging recent technological advancements, we were able to produce the borehole onto the platforms, into the pipelines, onto our gas facilities and right to the sales line. . . . Right now, we're producing about 6–6.5 million cubic feet per day from three of the wells. After some upcoming refinements, we expect production to be in the order of about 12–15 million cubic feet per day, and we anticipate that level of constant production for a couple of years."

To hear the full episode, visit https://ibn.fm/3jQkG

To view the full press release, visit https://ibn.fm/R4NJ4

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF), along with its consolidated subsidiaries, is a Canadian oil and gas exploration and production company with operations primarily focused in the Republic of Türkiye.

Headquartered in Canada, the company owns 49% of the SASB natural gas field, which is producing critical domestic supply of natural gas during Europe’s ongoing energy shortages. It also holds a 19.6% (except three wells with 9.8%) ownership interest in the Cendere Oil Field and has a farm-in agreement to earn 50% interest in three oil exploration blocks in southeast Türkiye called Cudi-Gabar.

Trillion Energy utilizes state-of-the-art technology and ingenious practices to produce and distribute oil and natural gas while still maintaining a commitment to sustainable and responsible operations. Whether through the development of new projects or optimizing existing assets, the company continues to seek new and innovative ways to drive growth and value for its stakeholders.

Headquartered in Vancouver, British Columbia, Trillion Energy is led by seasoned professionals who collectively boast over a century of energy exploration and development experience.

Projects

SASB Gas Field

The SASB Gas Field is producing and delivering critical domestic supplies of natural gas as energy shortages grip Europe due to Russia’s invasion of Ukraine.

Located in the southwestern Black Sea, the SASB gas field consists of numerous conventional natural gas pools located in shallow water. The fields have produced over 43 billion cubic feet (BCF) since initial development in 2007 and continue to provide much needed energy to Türkiye and the EU. Total infrastructure to date, including production platforms, pipelines, initial wells and gas processing plant, cost in excess of $600 million.

Trillion Energy is redeveloping the field with a strategic planned program of approximately 17 wells which commenced in 2022. Phase B of the program, targeted for 2024/25, consists of the re-entry of five legacy wells to drill sidetrack development wells and one exploration stratigraphic well.

Cendere Oil Field

Trillion Energy’s Cendere oil field is a long-term, low decline, stable oil production field located in Türkiye. The company has a 19.6% interest in the field, except for three wells in which its interest is 9.8%.

Cash flow after operating costs from the field is $120,000 to $140,000 per month, with average current production netting the company 110-120 barrels of oil per day. Estimated remaining Cendere oil reserves total 1.5 million barrels (0.277 million barrels net Trillion Energy).

The gross value of Trillion Energy’s interest is estimated at $13.85 million (NPV10).

Cudi-Gabar

Trillion Energy’s 10-well oil exploration drilling program is occurring on three prospective oil blocks located in the prolific Cudi-Gabar oil province in southeast Türkiye. The total area of the three blocks is 374,325 acres.

Trillion Energy’s potential 50% working and revenue interest in the blocks is earned by paying 100% of the work program costs. The company will operate the exploration program.
During 2023/24, Trillion Energy will shoot 351 kilometers of 2D seismic (150 km already shot on the eastern block) and drill four wells. The remaining six wells will be paid 50% by Trillion and 50% by the company’s partner. The oil blocks are surrounded by more than 10 major oil discoveries, half of which are recent.

Market Opportunity

A January 2024 report by Emergen Research, a market research and consulting company, estimated the global natural gas market at $310.5 trillion in 2022 and projected the market will be worth $443.8 trillion by 2032, achieving a CAGR of 3.7% during the forecast period. Increasing global economic activity and rising electricity consumption are key factors driving revenue growth of the market, according to the report.

Trillion Energy reports strong demand for natural gas in Türkiye, which is the seventh-largest natural gas consuming country in the world. Türkiye currently imports 98% of the natural gas it consumes, with about 60% of those imports coming from Iran and Russia.

Management Team

Dr. Arthur Halleran is CEO and Director of Trillion Energy. He has a Ph.D. in Geology from the University of Calgary and 44 years of petroleum exploration and development experience. His international experience includes work in Canada, Colombia, Egypt, India, Guinea, Sierra Leone, Sudan, Suriname, Chile, Brazil, Bulgaria, Türkiye, Pakistan, Peru, Tunisia, Trinidad Tobago, Argentina, Ecuador and Guyana. Dr. Halleran has worked for Petro-Canada, Chevron, Rally Energy and United Hydrocarbon International Corp. In 2007, he founded Canacol Energy Ltd., now the largest natural gas producer in Colombia.

Al Thorsen is COO of Trillion Energy. He is responsible for production operations of the SASB gas field, as well as future drilling activities in Türkiye and abroad. Highlights of his career include Valeura Energy Inc. as operations manager in Türkiye; Journey Energy, leading a production team; Rio Alto Exploration as country manager and production manager; Zargon Oil and Gas as VP of Operations; Orleans Energy as VP of Operations; and Central Petroleum as COO. He holds a Bachelor of Science in Petroleum Engineering from Montana College of Mineral Science & Technology.

Trillion Energy International Inc. (OTCQB: TRLEF), closed Tuesday's trading session at $0.0944, off by 0.6315789%, on 67,203 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0682/$1.06.

Recent News

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF)

The QualityStocks Daily Newsletter would like to spotlightFathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF).

An estimated 50% of all cars sold globally will be EVs by 2035, predicts the International Energy Agency's Global EV Outlook.

Fathom Nickel reports that the geochemical footprint of its Gochager Lake deposit has been extended by up to four kilometers.

Company "ecstatic" with the results from soil and rock geochemistry program, says CEO.

Despite headlines touting a slowing electric vehicle market, Forbes reports that actual data shows increasing sales, with projections indicating almost one-half of all cars sold in by 2035 will be EVs (https://ibn.fm/CuHiK). Those numbers are good news for Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), a company focused on exploring high-grade nickel sulfide discoveries for use in the global EV market, and a company that recently announced significant expansions to its historic nickel-copper-cobalt-producing ("Ni-Cu-Co") Gochager Lake Property (https://ibn.fm/0uQS9).

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian natural resource development and exploration company that targets high-grade nickel sulfide discoveries for use in the rapidly growing global electric vehicle (EV) market. The company has a portfolio of two high-quality exploration projects located in the prolific Trans Hudson Corridor in Saskatchewan.

Led by a management team with more than 100 years of combined mining and exploration experience, Fathom believes in a continuing bright outlook for nickel and its increasing use in the manufacturing of batteries needed for energy storage in the high-growth renewable energy and EV industries. The company’s modern approach to exploration has yielded significant new nickel discoveries.

Fathom is headquartered in Calgary, Alberta.

Projects

The Albert Lake Project

The Albert Lake Project comprises 90,460 hectares of lands located in north-central Saskatchewan, with over 80,000 hectares currently unexplored. The project is host to the historic Rottenstone Mine, a high-grade, open pit nickel sulfide past producer that was active from 1965 to 1969 and yielded ~26,000 tonnes of 3.3% Ni, 1.8% Cu, and >9 g/t Pd-Pt+Au.

The geological setting of the Albert Lake Project is within the Trans Hudson Orogeny (Corridor), which is host to numerous world-class nickel mining camps including the Thompson Nickel Belt (currently operating with more than 5 billion pounds of nickel produced since 1959), Lynn Lake (past producer) and Raglan Nickel Belt (currently operating with more than 39,000 tons of nickel produced in 2020).

The project is fully permitted. Exploration plans for 2024 include drilling a high-priority target located approximately 2km south of the historic Rottenstone Mine along with drilling other high-priority targets. Additional soil geochemistry, surface geophysical programs and geological mapping and prospecting will be performed during the summer field season.

The Gochager Lake Project

The Gochager Lake Project in northern Saskatchewan, also in the prolific Trans Hudson Corridor, was recently expanded through the addition of the contiguous Watt’s Lake property and direct staking, bringing its total land area to 22,620 hectares.

The Gochager Lake property is host to a historic resource defined by drilling in 1966-1967 consisting of 4.2 M tons grading 0.29% Ni and 0.08% Cu. Recent drilling by Fathom has defined multiple very robust off-hole borehole electromagnetic (BHEM) responses in eight of nine holes drilled in 2023 and three historic drill holes probed. There is very strong evidence of multiple, high-grade nickel-copper-cobalt steeply oriented chutes within the historic Gochager Lake Deposit.

Prior to Fathom exploration in 2023 and since 1970, exploration at the property has been limited to small drill programs in 1989-1990 and 2018. Exploration plans for 2024 include expanded surface geophysical programs, drilling and continued BHEM surveys to expand tons and increase the grade of the historic Gochager Lake deposit. Summer exploration will consist of soil geochemistry, mapping, prospecting and additional surface geophysical programs focused on identifying other Gochager-like deposits within the current land package.

Market Opportunity

Nickel plays a crucial role in clean energy technologies, and that is expected to cause demand to well outstrip supply for the foreseeable future.

With an annual market value of around $35 billion, nickel demand is projected to rise due to its intensive use in lithium-ion batteries used to power EVs. However, new discoveries of nickel sulfide deposits (currently the most reliable source for battery-grade class 1 nickel) have been rare, which could constrain class 1 nickel supply in the coming years.

According to Deloitte’s global EV forecast, total EV sales will grow from 2.5 million in 2020 to 11.2 million in 2025, reaching 31.1 million by 2030 and representing approximately 32% of the total market share for new car sales. Over the next 10 years, the EV market is projected to see a CAGR of 29%, with increased demand for nickel expected to be comparable.

Management Team

Fathom Nickel has assembled a best-in-class leadership team consisting of highly qualified industry professionals with deep knowledge and understanding of the mineral exploration industry and capital markets.

Ian Fraser, P.Geo., is CEO, VP Exploration and Co-Founder of Fathom Nickel. He has more than 35 years of experience in mineral exploration, as well as managing and implementing exploration projects in Canada and internationally. His experience includes resource interpretation and development of the Casa Berardi Gold Mine and Komis Gold Mine, as well as the Cisneros Gold Mine in Colombia.

Doug Porter, CPA, CA, CBV, is President, CFO and Director of Fathom Nickel. He is a senior financial and accounting executive with specific emphasis in resource company management. His career includes positions with Elan Coal Ltd., Altitude Resources Ltd. and StimWrx Oilfield Services Ltd.

Fathom Nickel Inc. (OTCQB: FNICF), closed Tuesday's trading session at $0.0254, off by 7.6364%, on 180,118 volume. The average volume for the last 3 months is 102,884 and the stock's 52-week low/high is $0.0222/$0.22715.

Recent News

PaxMedica Inc. (NASDAQ: PXMD)

The QualityStocks Daily Newsletter would like to spotlight PaxMedica Inc. (NASDAQ: PXMD).

PaxMedica Inc. (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (APTs) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms.

The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself.

PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions. Anti-purinergic therapies target the excess production of purines in cells. An overexpression of purines can offset homeostasis and result in an overproduction of cellular adenosine triphosphate, the main energy molecule in all living cells.

The company is headquartered in Tarrytown, New York.

Product Pipeline

PaxMedica is building a robust pipeline of products targeting ASD and related neurodevelopmental conditions. The company’s lead product in development may help eliminate, reduce or modulate some of the more troublesome aspects of ASD. That would open the potential for people with autism to integrate their behavior with others more successfully and improve their lives.

PaxMedica’s lead programs, PAX-101 and PAX-102, utilize the company’s proprietary source of suramin sodium, a broadly acting anti-purinergic therapy that has been known for over 100 years. Its current pipeline includes:

  • PAX-101 (IV Suramin) for ASD – PAX-101 completed a Phase 2B study for ASD in 2021. Suramin is a broadly acting APT and has reported positive results from a dose range study. The results of PaxMedica’s Phase 2B study, which targeted 52 subjects across six sites in South Africa, were presented to AACAP in October 2021.
  • PAX-102 (Intranasal Suramin) – PaxMedica has developed a proprietary intranasal formulation of suramin that is currently being evaluated in ASD and other neurodevelopmental conditions.
  • PAX-101 for HAT – Given suramin’s historical use as a treatment for Human African Trypanosomiasis (HAT), or African Sleeping Sickness, the company is also developing PAX-101 as a treatment for HAT. PaxMedica’s most advanced program is the pursuit of PAX-101 for early-stage East African HAT.
  • Selective APTs – PaxMedica has conducted several preclinical studies to evaluate other APTs that are more selective to specific purinergic receptors and may offer additional benefits over suramin.

Market Opportunity

According to a report by Fortune Business Insights, a leading global market research company, the global ASD therapeutics market was estimated at $1.93 billion in 2022 and is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, a CAGR of 7.9% over the forecast period. As there is no current treatment for the core symptoms of autism, PaxMedica believes the addressable market for PAX-101, if approved, could greatly exceed these forecasts.

Autistic disorder, Asperger’s Syndrome and Pervasive Development Disorder are the three main types of ASD, affecting millions of people globally. A 2020 report by the U.S. Centers for Disease Control & Prevention estimated that one in 36 children in the U.S. have been diagnosed with autism disorder.

Several factors are expected to contribute to market growth prospects. A growing prevalence of the condition globally and rising awareness coupled with available treatment options are key factors expected to drive ASD therapeutics market growth during the forecast period. Growing investment in R&D to find effective treatments is also expected to fuel global market growth.

Management Team

Howard Weisman is Chairman and CEO of PaxMedica. He has been a founder and CEO of several specialty pharma and medical device companies. Most recently, he was executive chairman and co-founder of Sofregen, a biotech company. He also served as CEO and president of Seventh Sense Biosystems, a medical device development company. He also was founder, chairman and CEO of EKR Therapeutics, a specialty pharmaceutical company, and founder and COO of ESP Pharma, a company focused on cardio and neurovascular products. He has a bachelor’s degree in chemistry from Rutgers University.

David Hough, M.D., is Chief Medical Officer at PaxMedica. He is a neuroscience clinical development consultant who previously served as vice president at Janssen Research and Development and in various leadership roles over 17 years. Most recently, he was the compound development team leader for SPRAVATO® for treatment-resistant depression. Prior to that, he was the schizophrenia disease area leader. He played a pivotal role in the development programs for oral INVEGA®, INVEGA SUSTENNA® and XEPLION® for schizophrenia. He is a graduate of West Point and is board certified in psychiatry.

Stephen Sheldon is COO and CFO at PaxMedica. He has served as CEO of Thailand-based specialty healthcare company Indochina Healthcare Co. Ltd. since 2015. Previously, he was a consultant for PricewaterhouseCoopers Healthcare Advisory in the Chicago office. He was responsible for developing specialty pharmacy patient programs, strategy development for specialty products and compliance programs. He has an MBA from Thunderbird School of Global Management and a bachelor’s degree in computer science and visual arts from Bowdoin College.

PaxMedica Inc. (NASDAQ: PXMD), closed Tuesday's trading session at $0.096, up 19.3288%, on 16,079 volume. The average volume for the last 3 months is 68,608 and the stock's 52-week low/high is $0.065/$10.26.

Recent News

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF)

The QualityStocks Daily Newsletter would like to spotlight Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF).

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) is an advanced stage gold exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project located in the Tier 1 district of the Southern Abitibi Greenstone belt of Rouyn-Noranda, Quebec. The Project has a 2011 historical mineral resource estimate of 727,000 ounces of Au at 5.42 g/t and an average thickness of 5.71 m*.

In 2023, with the use of AI (Artificial Intelligence), Emperor Metals created the first ever 3D mineralized and geological model, which illuminated the potential to add significant ounces to this deposit. Using these models, Emperor’s had a very successful 2023 drilling campaign of 8,579 m. In addition to laterally extending high grade zones by intercepting grades of 15.8 g/t Au over 10.8 meters, Emperor encountered intercepts of lower grade bulk tonnage in the host rocks (1.69 g/t Au over 25 m). This led to envisioning a different strategy of exploration and the revelation that a conceptual open-pit potentially overlies this high-grade gold deposit. Historic core sampling began (2,500 m) for discovering overlooked lower grade gold in the host rock around the high-grade lenses. Lower grade bulk tonnage gold improves the open-pit economics by reducing stripping ratios and adding overlooked incremental ounces for open pit mining.

Emperor Metals is set to begin a fully funded Phase II 8,000 m drilling program in May 2024. The company also plans on assaying an additional 8,000 m of historic core within the open pit model. Emperor is working toward producing an updated NI 43-101 Mineral Resource Estimate by Q1 2025.

The company is led by a dynamic group of resource sector professionals who have a strong record of success in evaluating and advancing mining projects from exploration through to production, attracting capital and overcoming adversity to deliver exceptional shareholder value.

Project

Emperor Metals has an option to earn 100% ownership of the Duquesne West Gold Project, a mineral claim package comprising 38 claims covering approximately 1,389 ha (3,432 acres) in Quebec.

The Duquesne West Gold Property is located 32 kilometers northwest of the city of Rouyn-Noranda and 10 kilometers east of the town of Duparquet. The property lies within the historic Duparquet gold mining camp in the southern portion of the Abitibi Greenstone Belt in the Superior Province.

Emperor is targeting the potential multimillion-ounce resource in a combination of conceptual open pit and underground mining scenarios. A Phase I drill campaign and historical core sampling program was completed in 2023, which included resource confirmation and exploration drilling, focusing on delineating and growing the resource toward development.

The property hosts a historical inferred mineral resource estimate of 727,000 ounces of gold at a grade of 5.42 grams per ton (g/t) and average stope thickness of 5.71 m. The mineral resource estimate predates modern Canadian Institute of Mining guidelines, and a Qualified Person on behalf of Emperor Metals has not reviewed or verified the mineral resource estimate. Therefore, it is considered historical in nature and is reported solely to provide an indication of the magnitude of mineralization that could be present on the property. The gold system remains open for resource identification and expansion.

Reinterpretation of the existing geological model was created using artificial intelligence and machine learning. This AI model shows the opportunity for additional discovery of ounces by revealing gold trends unknown to previous workers and the potential to expand the resource along significant gold-endowed structural zones. Multiple scenarios exist to expand additional resources, which include:

  • Underground High-Grade Gold
  • Open Pit Bulk Tonnage Gold
  • Underground Bulk Tonnage Gold

The Duquesne West-Ottoman property straddles the Porcupine-Destor gold localizing fault several kilometers east of the town of Duparquet. A number of previous drill campaigns have outlined an inferred resource of 4.17 million tons grading 5.42 g/t of gold (cut) or 6.36 g/t (uncut), as reported in the NI 43-101 report titled “Technical Report and Mineral Resource Estimate Update for the Duquesne-Ottoman Property, Quebec, Canada.”

Emperor Metals is funded for an 8,000-meter drilling program focusing primarily on adding ounces to the current resource within and lateral to the open pit model. An additional 8,000 m of historical core sampling and assaying is included in the budget to help build incremental ounces in the open-pit environment.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, to be worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

In May 2024, the market price of gold was approximately $2,340 per ounce.

Management Team

John Florek, P.Geol., is President, CEO and Director of Emperor Metals. He has more than 35 years of technical and senior management experience with major and junior mining companies, including roles as founder, vice president and director. He has helped identify and develop significant asset value for mines and exploration projects from grass roots through development. He has worked for several major mineral producers, including BHP, Placer Dome, Barrick, Teck and Detour Gold/Kirkland Lake Gold/Agnico Eagle.

Sean Mager is CFO and Director of Emperor Metals. He has worked more than 30 years in the mining sector, including extensive experience in corporate development, stakeholder relations, regulatory, financial and operations.

Alex Horsley is Head of Corporate Development and Director of Emperor Metals. He has more than 20 years of experience in the mining sector and capital markets with a focus on finance, marketing, management, corporate development and communications. He is founder and former CEO of Emperor Metals. He has assisted in raising more than C$40 million for exploration and development mining companies.

*Power-Fardy and Breede, 2011. The Mineral Resource Estimate (MRE) constructed in 2011 is considered historical in nature as it was constructed prior to the most recent Canadian Institute of Mining and Metallurgy (CIM) standards (2014) and guidelines (2019) for mineral resources. In addition, the economic factors used to demonstrate reasonable prospects of eventual economic extraction for the MRE have changed since 2011. A qualified person has not done sufficient work to consider the MRE as current. Emperor is not treating the historical MRE as current. The reader is cautioned not to treat it, or any part of it, as a current MRE.

Emperor Metals Inc. (OTCQB: EMAUF), closed Tuesday's trading session at $0.0677, up 10.6209%, on 246,938 volume. The average volume for the last 3 months is 71,625 and the stock's 52-week low/high is $0.058/$0.14505.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.